Hobart Kalkstein - Nov 10, 2023 Form 4 Insider Report for CABOT CORP (CBT)

Role
Executive Vice President
Signature
By: Jennifer Lombardi, pursuant to a power of attorney from Hobart C. Kalkstein
Stock symbol
CBT
Transactions as of
Nov 10, 2023
Transactions value $
-$1,441,811
Form type
4
Date filed
11/14/2023, 05:00 PM
Previous filing
Oct 3, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBT Common Stock Options Exercise $1.22M +24.5K +35.79% $50.00 92.9K Nov 10, 2023 Direct
transaction CBT Common Stock Sale -$1.81M -24.5K -26.36% $73.87 68.4K Nov 10, 2023 Direct F1
transaction CBT Common Stock Options Exercise $1.32M +26.2K +38.34% $50.23 94.6K Nov 10, 2023 Direct
transaction CBT Common Stock Sale -$1.94M -26.2K -27.71% $73.94 68.4K Nov 10, 2023 Direct F2
transaction CBT Common Stock Award $0 +4.44K +6.49% $0.00 72.8K Nov 10, 2023 Direct
transaction CBT Common Stock Tax liability -$236K -3.19K -4.38% $74.08 69.6K Nov 13, 2023 Direct
holding CBT Common Stock 7.05K Nov 10, 2023 Through the Trustee for the Corporation's 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBT Employee Stock Option (Right to Buy) Award $0 +14K $0.00 14K Nov 10, 2023 Common Stock 14K $74.40 Direct F3
transaction CBT Employee Stock Option (Right to Buy) Options Exercise $0 -24.5K -100% $0.00* 0 Nov 10, 2023 Common Stock 24.5K $50.00 Direct F4
transaction CBT Employee Stock Option (Right to Buy) Options Exercise $0 -26.2K -100% $0.00* 0 Nov 10, 2023 Common Stock 26.2K $50.23 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.805 to $73.935, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
F2 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.800 to $74.130, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
F3 The option vests over a three year period as follows: 30% on November 10, 2024, 30% on November 10, 2025 and 40% on November 10, 2026.
F4 24,475 shares were subject to the option. The option vested over a three year period as follows: 30% on November 9, 2019, 30% on November 9, 2020 and 40% on November 9, 2021.
F5 26,217 shares were subject to the option. The option vested over a three year period as follows: 30% on November 8, 2020, 30% on November 8, 2021 and 40% on November 8, 2022.